|
THAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.10980000031813E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.91919999681778E-08 |
| Normal-vs-Stage2 |
9.523500E-02 |
| Normal-vs-Stage3 |
2.755400E-01 |
| Normal-vs-Stage4 |
2.244800E-01 |
| Stage1-vs-Stage2 |
2.262400E-01 |
| Stage1-vs-Stage3 |
1.745530E-02 |
| Stage1-vs-Stage4 |
1.145350E-01 |
| Stage2-vs-Stage3 |
5.036200E-01 |
| Stage2-vs-Stage4 |
5.851200E-01 |
| Stage3-vs-Stage4 |
9.863000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.17209999986423E-07 |
| Normal-vs-AfricanAmerican |
2.020300E-03 |
| Normal-vs-Asian |
2.813800E-01 |
| Caucasian-vs-AfricanAmerican |
4.347800E-01 |
| Caucasian-vs-Asian |
9.077200E-01 |
| AfricanAmerican-vs-Asian |
8.877400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.18659999603921E-08 |
| Normal-vs-Female |
6.489500E-02 |
| Male-vs-Female |
9.844000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.960410E-03 |
| Normal-vs-Extreme_Weight |
7.90020000529523E-08 |
| Normal-vs-Obese |
8.231300E-04 |
| Normal-vs-Extreme_Obese |
2.608100E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.582800E-01 |
| Normal_Weight-vs-Obese |
7.788200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.584800E-01 |
| Extreme_Weight-vs-Obese |
1.027980E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.646400E-01 |
| Obese-vs-Extreme_Obese |
5.110000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.997800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.638590E-03 |
| Normal-vs-Age(61-80Yrs) |
3.96720001294426E-09 |
| Normal-vs-Age(81-100Yrs) |
4.55560000001132E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.888600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.325800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.019500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.481360E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.620500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.902200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.952599996777E-08 |
| Normal-VS-Type2 PRCC |
4.209800E-04 |
| Normal-VS-KIRP CIMP |
7.753200E-01 |
| Normal-VS-Unclassified PRCC |
2.216200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.084200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.892500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.828020E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.731000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.412400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.060000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.7088000000346E-07 |
| Normal-vs-N1 |
9.535200E-01 |
| Normal-vs-N2 |
2.361800E-02 |
| N0-vs-N1 |
1.582360E-03 |
| N0-vs-N2 |
8.141600E-01 |
| N1-vs-N2 |
2.659800E-01 |
|
|
